Kintara Therapeutics News

12 Health Care Stocks Moving In Friday's Pre-Market Session

GainersAkanda (NASDAQ:AKAN) shares rose 177.7% to $0.37 during Friday's pre-market session. The company's market cap stands at $11.7 million. Scorpius Holdings (AMEX:SCPX) stock increased by 28.17% to

BenzingaMay 17 07:07

Kintara Therapeutics Announces Upcoming Merger With TuHURA Biosciences

TipRanksMay 14 16:03

Kintara Therapeutics Q3 2024 GAAP EPS $(0.05)

Kintara Therapeutics (NASDAQ:KTRA) reported quarterly losses of $(0.05) per share.

BenzingaMay 14 16:02

10-Q: Quarterly report

SEC announcementMay 14 15:48 · Announcements

Press Release: Kintara Therapeutics Announces Fiscal 2024 Third Quarter Financial Results

Kintara Therapeutics Announces Fiscal 2024 Third Quarter Financial Results PR Newswire SAN DIEGO, May 14, 2024 SAN DIEGO, May 14, 2024 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Ki

Dow JonesMay 14 15:45

Kintara Therapeutics 3Q Loss/Shr 5c >KTRA

Kintara Therapeutics 3Q Loss/Shr 5c >KTRA

Dow JonesMay 14 15:45

Why Alphabet Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket

Shares of Alphabet Inc. (NASDAQ:GOOGL) (NASDAQ:GOOG) rose sharply in today's pre-market trading the company posted upbeat results for its first quarter.Google parent Alphabet said its first-quarter re

BenzingaApr 26 07:18

Kintara Therapeutics Eyes Merger Amidst Clinical Trial Buzz

TipRanksApr 25 08:22

Why Byrna Technologies Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Shares of Byrna Technologies Inc. (NASDAQ:BYRN) rose sharply during Friday's session after the company reported better-than-expected first-quarter revenue, and announced a CFO transition. Byrna Techno

BenzingaApr 5 12:06

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Kintara Therapeutics, Inc. Merger

Wilmington, Delaware--(Newsfile Corp. - April 4, 2024) - Rigrodsky Law, P.A. is investigating Kintara Therapeutics, Inc. ("Kintara") (NASDAQ: KTRA) regarding possible breaches of fiduciary duties and

newsfileApr 4 15:42

Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of STAAR Surgical Company (NASDAQ:STAA) rose sharply during Thursday's session after the company issued strong preliminary first-quarter net sales guidance. STAAR Surgical shares jumped 13.3%

BenzingaApr 4 12:21

Kintara (KTRA) Stock Soars on Merger Agreement With TuHURA

Yahoo FinanceApr 4 09:38

Sector Update: Health Care

Health care stocks were easing late Wednesday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) both decreasing 0.1%. The iShares Biotechnology ETF (IBB) she

MT NewswiresApr 3 14:38

Nasdaq Gains 75 Points; Acuity Brands Posts Upbeat Earnings

U.S. stocks traded higher toward the end of trading, with the S&P 500 gaining around 0.3% on Wednesday. The Dow traded up 0.08% to 39,200.08 while the NASDAQ rose 0.46% to 16,315.68. The S&P 500 also

BenzingaApr 3 13:30

Top Midday Gainers

Arca Biopharma (ABIO) and Oruka Therapeutics said Wednesday that they have agreed to merge in an all-stock deal. Shares soared 82% as intraday trading volume catapulted to more than 74 million versus

MT NewswiresApr 3 13:16

Shareholder Alert: Ademi LLP Investigates Whether Kintara Therapeutics, Inc. Has Obtained a Fair Price in Its Transaction With TuHURA

MILWAUKEE, April 3, 2024 /PRNewswire/ -- Ademi LLP is investigating Kintara (Nasdaq: KTRA) for possible breaches of fiduciary duty and other violations of law in its transaction with TuHURA. Click he

PR NewswireApr 3 12:43

FibroGen, Acorda Therapeutics, Enveric Biosciences Among Healthcare Movers

Seeking AlphaApr 3 09:00

US Stocks Edge Lower; Private Employment Tops Views

U.S. stocks traded lower this morning, following the release of ADP jobs data on Wednesday. Following the market opening Wednesday, the Dow traded down 0.08% to 39,139.63 while the NASDAQ fell 0.27% t

BenzingaApr 3 08:47

Why Kintara Therapeutics Shares Are Gaining Today

Kintara Therapeutics, Inc. (NASDAQ:KTRA) shares are trading higher in the premarket session on Wednesday with heavy volume.The company entered into a definitive merger agreement with TuHURA Bioscience

BenzingaApr 3 08:17

Trading Halt: Halt Status Updated at 7:25:00 AM ET: Quotation Resumption: News and Resumption Times

Trading Halt: Halt Status Updated at 7:25:00 AM ET: Quotation Resumption: News and Resumption Times

BenzingaApr 3 06:25